C12N 5/166
Resulting from interspecies fusion
Official title: {resulting from interspecies fusion}
C12N5/166 (Resulting from interspecies fusion) appears on 58 US grants and 49 published applications in this corpus.
Search patents in C12N- Granted patents
- 58
- Published applications
- 49
- Assignees
- 40
- Inventors
- 104
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 3 | 0 |
| 2002 | 3 | 3 |
| 2003 | 0 | 3 |
| 2004 | 1 | 1 |
| 2005 | 0 | 1 |
| 2006 | 2 | 2 |
| 2007 | 1 | 2 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 2 | 1 |
| 2015 | 4 | 6 |
| 2016 | 6 | 5 |
| 2017 | 3 | 6 |
| 2018 | 4 | 3 |
| 2019 | 1 | 3 |
| 2020 | 0 | 0 |
| 2021 | 0 | 3 |
| 2022 | 2 | 2 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 1 | 1 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modulating TLR/NF-KB and P53 signaling pathways to enhance interspecies chimerism between evolutionaryily distant species14 Jul 2026US 12,680,084 B2Board of Regents, The University of Texas System
- Developing an efficient hybridoma platform for therapeutic antibody discovery2 Dec 2025US 12,486,315 B2Genentech, Inc.
- Development of superior chimerism by hiPSC engineering and embryo aggregation2 Jan 2024US 11,859,213 B2Regents of the University of Minnesota
- Hybrid dairy cattle and systems for maximizing hybrid advantage23 Aug 2022US 11,419,316 B2ABS Global, Inc.
- Hybrid dairy cattle and systems for maximizing hybrid advantage2 Aug 2022US 11,399,521 B2ABS Global, Inc.
- Developing an efficient hybridoma platform for therapeutic antibody discovery26 Feb 2026US 2026/0055164 A1Genentech, Inc.
- Methods for large-size chromosomal transfer and modified chromosomes and organisims using same23 Jan 2025US 2025/0027116 A1Immunocan Biotech Co. Ltd.
- Three-dimensional culture of immortalized skin cells on the superficial layer of which a stratum corneum is formed, method for producing said three-dimensional culture, and method for evaluating test substance using said three-dimensional culture22 Aug 2024US 2024/0279606 A1National Institute of Advanced Industrial Science and Technology
- Modulating tlr/nf-kb and p53 signaling pathways to enhance interspecies chimerism between evolutionaryily distant species9 Mar 2023US 2023/0073534 A1Board of Regents, The University of Texas System
- Developing an efficient hybridoma platform for therapeutic antibody discovery9 Jun 2022US 2022/0177551 A1Genentech, Inc.
Most cited
By later US patents
- Production of a multimeric protein by cell fusion method411US 5,916,771 AAbgenix, Inc. · 1999
- Human-murine hybridoma fusion partner129US 4,634,666 AThe Board of Trustees of the Leland Stanford Junior University · 1987
- Process for the production of human mono-clonal antibodies92US 4,634,664 ASandoz Ltd. · 1987
- Production of multimeric protein by cell fusion method47US 6,420,140 B1Abgenix, Inc. · 2002
- Mammalian artificial chromosomes43US 5,288,625 ABiologic Research Center of the Hungarian Academy of Sciences · 1994